title: Localized skin necrosis of steroid-induced striae distensae: an unusual complication of bevacizumab and irinotecan therapy.
authors: Sabrina
authors: S
authors: Fourcade
authors: Caroline
authors: C
authors: Gaudy-Marqueste
authors: Anne-Marie
authors: AM
authors: Tasei
authors: Marie-Aleth
authors: MA
authors: Richard
authors: Jean-Jacques
authors: JJ
authors: Grob
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068258:Bevacizumab; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D059248:Chemoradiotherapy; D017809:Fatal Outcome; D005909:Glioblastoma / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D000077146:Irinotecan; D008297:Male; D008776:Methylprednisolone Hemisuccinate / Q000009:adverse effects* / Q000627:therapeutic use; D009336:Necrosis; D012867:Skin / Q000187:drug effects*; D057896:Striae Distensae / Q000139:chemically induced / Q000473:pathology*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068258:Bevacizumab; D008776:Methylprednisolone Hemisuccinate; D000077146:Irinotecan; D002166:Camptothecin